SlideShare ist ein Scribd-Unternehmen logo
1 von 64
Downloaden Sie, um offline zu lesen
EVICEL Fibrin Sealant (Human) Product Information EVICEL TM  Fibrin Sealant (Human) PSR Sales Training Module
Training Road Map ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Biosurgicals Products EVICEL* FIBRIN SEALANT (HUMAN) ORC (Oxidized Regenerated  Cellulose) GELATIN FLOWABLE GELATIN COLLAGEN FIBRIN SEALANT SURGICEL* Hemostats SURGICEL FIBRILLAR* Hemostats SURGICEL NU-KNIT* Hemostats SURGIFOAM* GELATIN SPONGE & POWDER Hemostats INSTAT*  MICROFIBRILLARCOLLAGEN Hemostats SURGIFOAM* POWDER Kit SURGIFLO* Hemostatic Matrix THROMBIN EVITHROM* Thrombin, Topical (Human)
Fibrin Sealant Market Overview
U.S. Fibrin Market *IMS Data, 2007 Vitagel EVICEL Tisseel 2006 Fibrin Market ($92 MM) 2007 Fibrin Market ($103 MM est.) Total fibrin market grew by 12% in 2007 Source: IMS 2007
EVICEL Performance 2005 $183,364 $847,628 $1.2MM $1.9MM $2.2MM $2.2MM $3.1MM $3.6MM $4.2MM $5.3MM Launched  EVICEL Launched  CROSSEAL Launched  EVICEL Vascular 2006 2007 $6.1MM $8.4 MM $7.1 MM Launched  EVICEL General  Hemostasis $8.8MM 2008 $10.4MM YTD in 2007 vs  $17.7MM YTD in 2008 70% growth over 2007!!!
122% -15% 37% The Fibrin Sealants segment increased 18% over previous quarter and 14% over 4Q ’06 to $27.3M this quarter.  Evicel leads the growth, with almost $5M growth in the past year and $0.7M in the past quarter.  Although Tisseel is down over the past year, it rebounded in 4Q ’07 after its drop in 3Q ’07.  Tisseel is cannibalizing its VH (nonfrozen) business with the newer frozen formulations which now account for 22% of its total dollar volume US Biosurgicals Market: Fibrin Sealants Detailed Segment, Short-term  Dollar  Performance 3 Month Quarters, $ Volume, in Millions Growth  over  Pr. Yr. Segment Volume (MM) $3.9 $5.8 $8.2 $8.3 $8.8 $17.0 $17.5 $14.3 $11.4 $12.0 $3.5 $3.4 $2.9 $3.5 $4.0 $- $5 $10 $15 $20 $25 $30 4Q '06 1Q '07 2Q '07 3Q '07 4Q '07 $, Millions Evicel Tisseel Vitagel Source:  IMS HIS Data Compiled by:  Pinky Shaw, BIWW
Plastic/Burn Surgery Market Overview **NOTE:  As always, promotion only for on-label surgeries for hemostasis $764MM 1,038,000 TOTAL $338MM 735,000 Breast  (Reconstruction, Lift, Reduction and augmentation)   (5 mL) $100MM 100,000 Burn Surgery (10 mL) $240MM 160,000 Abdominoplasty (15 mL) $86MM 43,000 Massive Weight Loss Body Contouring (20 mL) Potential Market (100% Penetration) Volume Procedure
Procedures to Target ,[object Object],[object Object],[object Object],Plastic Procedures
Background & New Indication
J&J Collaboration Framework ,[object Object]
EVICEL General Hemostasis  Indication Expected in January 2008 ,[object Object],[object Object],[object Object],[object Object],[object Object]
New Opportunities in Plastic Surgery ,[object Object],[object Object],[object Object]
EVICEL Selling Cycle ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
New Indication for EVICEL TM   EVICEL TM  Fibrin Sealant (Human) is indicated  as an adjunct to hemostasis for patients  undergoing  surgery  when control of bleeding by standard surgical techniques is ineffective or impractical * Pending final labeling from FDA
EVICEL ™  Fibrin Sealant (Human) Original Promotional Road Map Does the surgeon  operate on the liver? Sales rep  can also respond  to a training request Sales rep or Medical Affairs *  can respond to request for clinical info. Yes Yes You and the customer  can initiate questions on EVICEL Fibrin Sealant (Human) for the approved indication Can  you  (sales rep) initiate conversation  on EVICEL Fibrin Sealant (Human)  for the approved indication? Can  you  (sales rep) respond to clinical questions on EVICEL Fibrin Sealant (Human) for the approved indication? Yes Only  customers  can initiate questions  on EVICEL Fibrin Sealant (Human)  No Only  Medical Affairs *  can respond  to request for off-label clinical  information on fibrin glue Sales rep could provide proper usage instructions upon request (including indications & safety information) to customers who decide to use the product  Can  you  (sales rep) respond  to off-label clinical questions on  EVICEL Fibrin Sealant (Human)? Can  you  (Sales rep) initiate conversation on EVICEL Fibrin Sealant (Human)? No Training should include Indications, Contraindications,  Precautions, Warnings, and the technical aspects of the product. * Pending final labeling from FDA No
EVICEL ™  Fibrin Sealant (Human) Vascular Promotional Road Map Does the surgeon operate on the liver  or perform vascular surgery? Sales rep  can also respond  to a training request Sales rep or Medical Affairs *  can respond to request for clinical info. Yes Yes You and the customer  can initiate questions on EVICEL Fibrin Sealant (Human) for the approved indication Can  you  (sales rep) initiate conversation  on EVICEL Fibrin Sealant (Human)  for the approved indication? Can  you  (sales rep) respond to clinical questions on EVICEL Fibrin Sealant (Human) for the approved indication? Yes Only  customers  can initiate questions  on EVICEL Fibrin Sealant (Human)  No Only  Medical Affairs *  can respond  to request for off-label clinical  information on fibrin glue Sales rep could provide proper usage instructions upon request (including indications & safety information) to customers who decide to use the product  Can  you  (sales rep) respond  to off-label clinical questions on  EVICEL Fibrin Sealant (Human)? Can  you  (Sales rep) initiate conversation on EVICEL Fibrin Sealant (Human)? No Training should include Indications, Contraindications,  Precautions, Warnings, and the technical aspects of the product. * Pending final labeling from FDA No
EVICEL ™  Fibrin Sealant (Human) General Hemostasis Promotional Road Map Sales rep or Medical Affairs  can respond to request for clinical info. Yes Yes You and the customer  can initiate questions on EVICEL for the approved indication Can  you  (sales rep) initiate conversation  on EVICEL for the approved indication? Can  you  (sales rep) respond to clinical questions on EVICEL for the approved indication? Only  customers  can initiate questions  on EVICEL for off-label uses No, cannot promote for off-label uses, such as sealing and fixation Only  Medical Affairs  can respond  to request for off-label clinical  information on fibrin glues Can  you  (sales rep) respond  to off-label clinical questions on  EVICEL Fibrin Sealant (Human)? Can  you  (Sales rep) initiate conversation on off-label uses? No Training should include Indications, Contraindications,  Precautions, Warnings, and the technical aspects of the product. Promote On-label for Hemostasis? Does the surgeon perform surgery? Yes * Pending final labeling from FDA No
Customer Requests for Clinical Information ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Leverage our Broad GH Indication Retroperitoneal Bleeding/Soft Tissue (3) Peripheral Vascular Surgery (2) Liver Resection Surgery (1) General Hemostasis Indication Studied in 3 different tissue types
Soft Tissue Study Highlights ENDPOINTS / CONCLUSIONS ,[object Object],[object Object],[object Object],[object Object],[object Object],* Pending final labeling from FDA
Competitive Overview
US Indications Differ by Fibrin Sealant Brand 1, 2 - Sources:  US FDA Approved Package Inserts for Tisseel, Evicel TM   & Artiss Note: Information from respective prescribing information derived from separate clinical studies - not intended to convey comparative safety or efficacy.  ,[object Object],[object Object],TISSEEL  (Fibrin Sealant)  Pre-Filled Syringe (Frozen) (Baxter) Indication Statements ,[object Object],[object Object],ARTISS   (Fibrin Sealant)   (Baxter) Product ,[object Object]
Indications by Fibrin Sealant Sources:  US FDA Approved Package Inserts for Tisseel, Evicel TM   & Artiss Note: Information from respective prescribing information derived from separate clinical studies - not intended to convey comparative safety or efficacy.  To adhere autologous  skin grafts to surgically prepared  wound beds resulting from burns  Adjunct to hemostasis in patients undergoing surgeries involving Cardio- pulmonary bypass ,[object Object],[object Object],TISSEEL Not indicated for hemostasis ARTISS Adjunct to hemostasis for use in patients undergoing surgery Ortho Burns Plastics GYN Urology CV PV General
Fibrinogen & Thrombin Content*  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],*EVICEL TM   Fibrin Sealant (Human) Artiss & Tisseel Fibrin Sealant Package Inserts 1. Sierra D. Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications.  Journal of Applied Biomaterials. Vol.3. 1992: 147-151. Note:  Not intended to convey comparative safety or efficacy. EVICEL TM  Fibrin Sealant TISSEEL Fibrin Sealant ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],ARTISS Fibrin Sealant EVICEL TM  does not contain aprotinin and does not expose patients to the risks associated with aprotinin EVICEL TM  does not require an antifibrinolytic stabilizer (ex: aprotinin)  agent due to the removal of plasminogen from its formulation Normal fibrin clot is produced with approximately 2–5 mg/mL of fibrinogen 1
Clot Longevity Comparison* Longevity of the EVICEL TM  Fibrin Sealant (Human) clot in vivo is comparable to that of CROSSEAL* Fibrin Sealant, and other marketed fibrin sealants such as Tisseel *Johnson & Johnson Wound Management Data on File, Data from in vitro animal model
EVICEL TM  Product Training
Think EVICEL TM  for your Plastic Surgery Procedures EVICEL TM  is the  first  and  only  fibrin sealant approved for general hemostasis in surgery 1 TRAM Flap Abdominoplasty Think 1.  Full Prescribing Information.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],EVICEL™ Fibrin Sealant (Human) INDICATION: An adjunct to hemostasis for use in patients undergoing surgery when control of bleeding by standard surgical techniques is ineffective or impractical Important Safety Information
EVICEL™ Fibrin Sealant (Human) ,[object Object],[object Object],[object Object],[object Object],A safe and effective all-human fibrin sealant that doesn’t require an antifibrinolytic agent, while maintaining  clot stability 1.  Full Prescribing Information. 2.  Data on File. ETHICON, INC.
EVICEL™ Fibrin Sealant (Human) ,[object Object],[object Object],[object Object],Hemostasis can begin quickly with less preparation time and minimal clogging Triple-lumen tip  —  resists clogging 1.  Full Prescribing Information. 2.  Data on File. ETHICON, INC. Thaws within 10 minutes at 37 0 C; within 1 hour at 20 0 C to 25 0 C (room temperature); or within 1 day at 2 0 C to 8 0 C (refrigerator).
EVICEL™ Fibrin Sealant (Human) ,[object Object],[object Object],[object Object],[object Object],[object Object],Designed to keep you focused on your procedure – Clear and stable clot 1 1.  Full Prescribing Information, see EVICEL TM  Package Insert 2.  Data on File. ETHICON, INC.
Biologics – Thrombin & BAC2 1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],1.  Full Prescribing Information.
Device Overview 2 luer locks for easy removal and  attachment of accessory tips  Triple lumen 7cm clog resistant applicator tip Optional 35cm  Rigid Tip Can be sprayed or dripped from the same device
35 cm Rigid Tip Overview EVICEL 35 cm Rigid Tip Packaging (3 per box) Ready to spray or drip One-Handed delivery Atraumatic & clog-resistant tip (triple lumen runs throughout tip) Attaches easily to the device
Pressure Regulator EVICEL TM  Fibrin Sealant (Human) should be sprayed using  an air pressure of 20–25 psi measured by air flow* * EVICEL TM  Fibrin Sealant (Human) Pressure Regulator Instructions for Use
Preparation Video
EVICEL™ Fibrin Sealant (Human)  Summary 1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],1.  Full Prescribing Information.
Plastic Surgery Sales Tools
Updated Main Sales Aid NOW  the  only  fibrin sealant approved for general hemostasis in surgery New Effective Bullet: Proven Rapid Hemostasis in vascular, urologic, gynecologic and  general surgery New Soft Tissue Study   data   in general, gynecologic and urologic surgery * Pending final labeling from FDA; Draft Piece-Subject to change
New  Plastics  Slim Jim  Plastics Images (Breast Reconstruction) Hemostatic Efficacy (New Soft Tissue Study Data) in general, gynecologic and urologic surgery Experience the   clear choice   for your plastic surgery  procedures Spray or drip EVICEL™ to achieve hemostasis during reconstructive procedures, including:  breast reconstruction, abdominoplasty, facial reconstruction and vascular anastomoses * Subject to FDA Review * Pending final labeling from FDA; Draft Piece-Subject to change
Customer Requests for Clinical Information ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Product Preparation Poster New Cling-zee OR Wall Poster Easy preparation: No mixing required New easy-to-see images Preparation instructions for the 35 cm Rigid Tip
EVICEL Product Codes
New Customer In-service Deck (Updated with new indication & modular device) New Updated Website (New specialty tabs in Ortho, Burns & Plastics) New Blackberry Videos (3 new videos in Ortho, Burns & Plastics)
EVICEL in Plastic Surgery Overview
Plastic & Burn Specialty Overview
Why I Use Fibrin Sealants  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Where I Use Fibrin Sealant ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Abdominoplasty Steps of Procedure &  Bleeding Challenges
Abdominoplasty ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Breast Reconstruction – Flap ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Breast Reconstruction – Implant ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Facial Surgery ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Scar Revision ,[object Object],Bleeding Challenges
Scar Revision ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],For Internal Use Only
Scar Revision
Surgery Videos
Breast Reconstruction
Q&A
[object Object]
[object Object]
2008 Goals Develop new customers and markets (Ortho, Plastics & Burns) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Capture   competitive market share Create  new markets Protect   our existing business Maintain & Protect our existing business - Main Sales Aid   - Product Monograph   - FDA approval letter    - Press Release   - Plastics Slim Jim   - Burn Slim Jim   - Ortho Slim Jim Sales Tools: Sales Tools:   - Contracting Strategy   - Main Sales Aid   Sales Tools:
Burn Surgery ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Weitere ähnliche Inhalte

Was ist angesagt?

Pulmonary drug delivery system [PDDS]
Pulmonary drug delivery system [PDDS]Pulmonary drug delivery system [PDDS]
Pulmonary drug delivery system [PDDS]Sagar Savale
 
Modified drug release - Pharmaceutics
Modified drug release - PharmaceuticsModified drug release - Pharmaceutics
Modified drug release - PharmaceuticsAreej Abu Hanieh
 
Formulation and Evaluation of Buccal Drug delivery system.pptx
Formulation and Evaluation of Buccal Drug delivery system.pptxFormulation and Evaluation of Buccal Drug delivery system.pptx
Formulation and Evaluation of Buccal Drug delivery system.pptxAdithya B S
 
Pharmaceutical Packaging Industry
Pharmaceutical Packaging IndustryPharmaceutical Packaging Industry
Pharmaceutical Packaging IndustryChiraag Naithani
 
Hot melt extrusion
Hot melt extrusionHot melt extrusion
Hot melt extrusionmanmanasi
 
Surgical ligatures and sutures
Surgical ligatures and suturesSurgical ligatures and sutures
Surgical ligatures and suturesChirag Goda
 
Ocular drug delivery system
Ocular drug delivery systemOcular drug delivery system
Ocular drug delivery systemPAYALBORAWAKE
 
PHARMACEUTICAL INDUSTRIAL TRAINING REPORT .pdf
PHARMACEUTICAL INDUSTRIAL TRAINING REPORT .pdfPHARMACEUTICAL INDUSTRIAL TRAINING REPORT .pdf
PHARMACEUTICAL INDUSTRIAL TRAINING REPORT .pdfRonakBhambri
 
biopharmaceutical factors affecting drug bioavailability.pptx
biopharmaceutical factors affecting drug bioavailability.pptxbiopharmaceutical factors affecting drug bioavailability.pptx
biopharmaceutical factors affecting drug bioavailability.pptxanumalagundam sreekanth
 
Nasal Drug Delivery System
Nasal Drug Delivery SystemNasal Drug Delivery System
Nasal Drug Delivery SystemKawitha
 
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HCl
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HClFORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HCl
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HClMohammad Adil
 
Topical hemostatic agents in surgical practice
Topical hemostatic agents in surgical practiceTopical hemostatic agents in surgical practice
Topical hemostatic agents in surgical practiceanemo_site
 
Compression and compaction
Compression and compactionCompression and compaction
Compression and compactionSagar Savale
 
Drug delivery system, by dr. umesh kumar sharma & shyma ms
Drug delivery system, by dr. umesh kumar sharma & shyma msDrug delivery system, by dr. umesh kumar sharma & shyma ms
Drug delivery system, by dr. umesh kumar sharma & shyma msDr. UMESH KUMAR SHARMA
 
STANDARD OPERATING PROCEDURES FOR PARENTERAL DOSAGE FORM PREPARATION
STANDARD OPERATING PROCEDURES FOR PARENTERAL DOSAGE FORM PREPARATIONSTANDARD OPERATING PROCEDURES FOR PARENTERAL DOSAGE FORM PREPARATION
STANDARD OPERATING PROCEDURES FOR PARENTERAL DOSAGE FORM PREPARATIONAVIJIT BAKSHI
 
OCCULAR DRUG DELIVERY SYSTEM-pawan -.ppt
OCCULAR DRUG DELIVERY SYSTEM-pawan -.pptOCCULAR DRUG DELIVERY SYSTEM-pawan -.ppt
OCCULAR DRUG DELIVERY SYSTEM-pawan -.pptPawanDhamala1
 

Was ist angesagt? (20)

Pulmonary drug delivery system [PDDS]
Pulmonary drug delivery system [PDDS]Pulmonary drug delivery system [PDDS]
Pulmonary drug delivery system [PDDS]
 
Modified drug release - Pharmaceutics
Modified drug release - PharmaceuticsModified drug release - Pharmaceutics
Modified drug release - Pharmaceutics
 
Formulation and Evaluation of Buccal Drug delivery system.pptx
Formulation and Evaluation of Buccal Drug delivery system.pptxFormulation and Evaluation of Buccal Drug delivery system.pptx
Formulation and Evaluation of Buccal Drug delivery system.pptx
 
Pharmaceutical Packaging Industry
Pharmaceutical Packaging IndustryPharmaceutical Packaging Industry
Pharmaceutical Packaging Industry
 
Hot melt extrusion
Hot melt extrusionHot melt extrusion
Hot melt extrusion
 
Surgical ligatures and sutures
Surgical ligatures and suturesSurgical ligatures and sutures
Surgical ligatures and sutures
 
Ocular drug delivery system
Ocular drug delivery systemOcular drug delivery system
Ocular drug delivery system
 
PHARMACEUTICAL INDUSTRIAL TRAINING REPORT .pdf
PHARMACEUTICAL INDUSTRIAL TRAINING REPORT .pdfPHARMACEUTICAL INDUSTRIAL TRAINING REPORT .pdf
PHARMACEUTICAL INDUSTRIAL TRAINING REPORT .pdf
 
biopharmaceutical factors affecting drug bioavailability.pptx
biopharmaceutical factors affecting drug bioavailability.pptxbiopharmaceutical factors affecting drug bioavailability.pptx
biopharmaceutical factors affecting drug bioavailability.pptx
 
Colon specific drug delivery system
Colon specific drug delivery systemColon specific drug delivery system
Colon specific drug delivery system
 
Nasal Drug Delivery System
Nasal Drug Delivery SystemNasal Drug Delivery System
Nasal Drug Delivery System
 
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HCl
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HClFORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HCl
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HCl
 
Sonophoresis
Sonophoresis Sonophoresis
Sonophoresis
 
Topical hemostatic agents in surgical practice
Topical hemostatic agents in surgical practiceTopical hemostatic agents in surgical practice
Topical hemostatic agents in surgical practice
 
G
GG
G
 
Compression and compaction
Compression and compactionCompression and compaction
Compression and compaction
 
Adme
AdmeAdme
Adme
 
Drug delivery system, by dr. umesh kumar sharma & shyma ms
Drug delivery system, by dr. umesh kumar sharma & shyma msDrug delivery system, by dr. umesh kumar sharma & shyma ms
Drug delivery system, by dr. umesh kumar sharma & shyma ms
 
STANDARD OPERATING PROCEDURES FOR PARENTERAL DOSAGE FORM PREPARATION
STANDARD OPERATING PROCEDURES FOR PARENTERAL DOSAGE FORM PREPARATIONSTANDARD OPERATING PROCEDURES FOR PARENTERAL DOSAGE FORM PREPARATION
STANDARD OPERATING PROCEDURES FOR PARENTERAL DOSAGE FORM PREPARATION
 
OCCULAR DRUG DELIVERY SYSTEM-pawan -.ppt
OCCULAR DRUG DELIVERY SYSTEM-pawan -.pptOCCULAR DRUG DELIVERY SYSTEM-pawan -.ppt
OCCULAR DRUG DELIVERY SYSTEM-pawan -.ppt
 

Andere mochten auch

H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014
H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014
H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014H.B. Fuller
 
Use Of Tissue Sealants And Hemostatic Agents
Use Of Tissue Sealants And Hemostatic AgentsUse Of Tissue Sealants And Hemostatic Agents
Use Of Tissue Sealants And Hemostatic AgentsMCG Urology
 
Gums, Adhesives & Sealants Technology
Gums, Adhesives & Sealants TechnologyGums, Adhesives & Sealants Technology
Gums, Adhesives & Sealants TechnologyAjjay Kumar Gupta
 
Clay brick making machine industry,indian bricks sector,indian brick industry...
Clay brick making machine industry,indian bricks sector,indian brick industry...Clay brick making machine industry,indian bricks sector,indian brick industry...
Clay brick making machine industry,indian bricks sector,indian brick industry...Ken Research Pvt ltd.
 
Brick Classification
Brick ClassificationBrick Classification
Brick ClassificationSteve Jarvis
 
Hemostasis, surgical bleeding and transfusion
Hemostasis, surgical bleeding and transfusionHemostasis, surgical bleeding and transfusion
Hemostasis, surgical bleeding and transfusionMae Martinquilla
 
Business plan on fly ash bricks
Business plan on fly ash bricksBusiness plan on fly ash bricks
Business plan on fly ash bricksAtikant Kashyap
 
Classification of bricks as per conventional standard
Classification of bricks as per conventional standardClassification of bricks as per conventional standard
Classification of bricks as per conventional standarddezyneecole
 

Andere mochten auch (17)

H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014
H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014
H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014
 
Use Of Tissue Sealants And Hemostatic Agents
Use Of Tissue Sealants And Hemostatic AgentsUse Of Tissue Sealants And Hemostatic Agents
Use Of Tissue Sealants And Hemostatic Agents
 
O’Hare Modernization Program
O’Hare Modernization ProgramO’Hare Modernization Program
O’Hare Modernization Program
 
Khalid.ppt
Khalid.pptKhalid.ppt
Khalid.ppt
 
Gums, Adhesives & Sealants Technology
Gums, Adhesives & Sealants TechnologyGums, Adhesives & Sealants Technology
Gums, Adhesives & Sealants Technology
 
Tissue sealant essentials
Tissue sealant essentialsTissue sealant essentials
Tissue sealant essentials
 
Clay brick making machine industry,indian bricks sector,indian brick industry...
Clay brick making machine industry,indian bricks sector,indian brick industry...Clay brick making machine industry,indian bricks sector,indian brick industry...
Clay brick making machine industry,indian bricks sector,indian brick industry...
 
Brick Classification
Brick ClassificationBrick Classification
Brick Classification
 
Hemostasis, surgical bleeding and transfusion
Hemostasis, surgical bleeding and transfusionHemostasis, surgical bleeding and transfusion
Hemostasis, surgical bleeding and transfusion
 
Bricks fin
Bricks finBricks fin
Bricks fin
 
Construction Sealants
Construction SealantsConstruction Sealants
Construction Sealants
 
Management of Surgical Hemostasis: An Independent Study Guide
Management of Surgical Hemostasis: An Independent Study GuideManagement of Surgical Hemostasis: An Independent Study Guide
Management of Surgical Hemostasis: An Independent Study Guide
 
Business plan on fly ash bricks
Business plan on fly ash bricksBusiness plan on fly ash bricks
Business plan on fly ash bricks
 
Classification of bricks as per conventional standard
Classification of bricks as per conventional standardClassification of bricks as per conventional standard
Classification of bricks as per conventional standard
 
Bricks
Bricks Bricks
Bricks
 
Brics ppt
Brics pptBrics ppt
Brics ppt
 
Testovi sa resenjima
Testovi sa resenjimaTestovi sa resenjima
Testovi sa resenjima
 

Ähnlich wie Plastics

HIV Lipoatrophy 2007
HIV Lipoatrophy 2007HIV Lipoatrophy 2007
HIV Lipoatrophy 2007VHCONCEPTS
 
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017Fight Colorectal Cancer
 
SUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical Center
SUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical CenterSUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical Center
SUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical CenterGoLeanSixSigma.com
 
Exercise No 4 How To Label Intravenous Fluid
Exercise  No 4    How To  Label  Intravenous  FluidExercise  No 4    How To  Label  Intravenous  Fluid
Exercise No 4 How To Label Intravenous Fluiddunerafael
 
Surgical safety checklist issued by who
Surgical safety checklist issued by whoSurgical safety checklist issued by who
Surgical safety checklist issued by whoVin Williams
 
10 step marketing plan for aforvir
10 step marketing plan for aforvir10 step marketing plan for aforvir
10 step marketing plan for aforvirRalph Raymund Pinon
 
Macrolane Breast Enhancement - Paris
Macrolane Breast Enhancement  - ParisMacrolane Breast Enhancement  - Paris
Macrolane Breast Enhancement - ParisAuroraClinics
 
Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014Pete Shuster
 
cGMP Case Study Training
cGMP Case Study TrainingcGMP Case Study Training
cGMP Case Study Trainingguestaa38de
 
Milestone Scientific Inc. Investor Presentation April 2021
Milestone Scientific Inc. Investor Presentation April 2021Milestone Scientific Inc. Investor Presentation April 2021
Milestone Scientific Inc. Investor Presentation April 2021RedChip Companies, Inc.
 

Ähnlich wie Plastics (20)

Action proposal
Action proposalAction proposal
Action proposal
 
HIV Lipoatrophy 2007
HIV Lipoatrophy 2007HIV Lipoatrophy 2007
HIV Lipoatrophy 2007
 
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
 
SUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical Center
SUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical CenterSUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical Center
SUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical Center
 
Exercise No 4 How To Label Intravenous Fluid
Exercise  No 4    How To  Label  Intravenous  FluidExercise  No 4    How To  Label  Intravenous  Fluid
Exercise No 4 How To Label Intravenous Fluid
 
Surgical safety checklist issued by who
Surgical safety checklist issued by whoSurgical safety checklist issued by who
Surgical safety checklist issued by who
 
Bioheart (OTC: BHRT; Twitter: $BHRT)
Bioheart (OTC: BHRT; Twitter: $BHRT)Bioheart (OTC: BHRT; Twitter: $BHRT)
Bioheart (OTC: BHRT; Twitter: $BHRT)
 
MLSS Investor Presentation August 2021
MLSS Investor Presentation August 2021MLSS Investor Presentation August 2021
MLSS Investor Presentation August 2021
 
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. FischellPCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
 
10 step marketing plan for aforvir
10 step marketing plan for aforvir10 step marketing plan for aforvir
10 step marketing plan for aforvir
 
MLSS Investor Presentation June 2021
MLSS Investor Presentation June 2021MLSS Investor Presentation June 2021
MLSS Investor Presentation June 2021
 
Macrolane Breast Enhancement - Paris
Macrolane Breast Enhancement  - ParisMacrolane Breast Enhancement  - Paris
Macrolane Breast Enhancement - Paris
 
erbitux
erbituxerbitux
erbitux
 
MLSS Investor Presentation October2021
MLSS Investor Presentation October2021MLSS Investor Presentation October2021
MLSS Investor Presentation October2021
 
The Future of the Pharmaceutical Industry in Spain
The Future of the Pharmaceutical Industry in SpainThe Future of the Pharmaceutical Industry in Spain
The Future of the Pharmaceutical Industry in Spain
 
Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014
 
Evolence Dermal Filler
Evolence Dermal FillerEvolence Dermal Filler
Evolence Dermal Filler
 
cGMP Case Study Training
cGMP Case Study TrainingcGMP Case Study Training
cGMP Case Study Training
 
Resumegreg
ResumegregResumegreg
Resumegreg
 
Milestone Scientific Inc. Investor Presentation April 2021
Milestone Scientific Inc. Investor Presentation April 2021Milestone Scientific Inc. Investor Presentation April 2021
Milestone Scientific Inc. Investor Presentation April 2021
 

Kürzlich hochgeladen

4.9.24 Social Capital and Social Exclusion.pptx
4.9.24 Social Capital and Social Exclusion.pptx4.9.24 Social Capital and Social Exclusion.pptx
4.9.24 Social Capital and Social Exclusion.pptxmary850239
 
BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (GLOB...
BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (GLOB...BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (GLOB...
BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (GLOB...Nguyen Thanh Tu Collection
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfPrerana Jadhav
 
Satirical Depths - A Study of Gabriel Okara's Poem - 'You Laughed and Laughed...
Satirical Depths - A Study of Gabriel Okara's Poem - 'You Laughed and Laughed...Satirical Depths - A Study of Gabriel Okara's Poem - 'You Laughed and Laughed...
Satirical Depths - A Study of Gabriel Okara's Poem - 'You Laughed and Laughed...HetalPathak10
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17Celine George
 
Indexing Structures in Database Management system.pdf
Indexing Structures in Database Management system.pdfIndexing Structures in Database Management system.pdf
Indexing Structures in Database Management system.pdfChristalin Nelson
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvRicaMaeCastro1
 
MS4 level being good citizen -imperative- (1) (1).pdf
MS4 level   being good citizen -imperative- (1) (1).pdfMS4 level   being good citizen -imperative- (1) (1).pdf
MS4 level being good citizen -imperative- (1) (1).pdfMr Bounab Samir
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseCeline George
 
Scientific Writing :Research Discourse
Scientific  Writing :Research  DiscourseScientific  Writing :Research  Discourse
Scientific Writing :Research DiscourseAnita GoswamiGiri
 
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQ-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQuiz Club NITW
 
Employablity presentation and Future Career Plan.pptx
Employablity presentation and Future Career Plan.pptxEmployablity presentation and Future Career Plan.pptx
Employablity presentation and Future Career Plan.pptxryandux83rd
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationdeepaannamalai16
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management SystemChristalin Nelson
 
ClimART Action | eTwinning Project
ClimART Action    |    eTwinning ProjectClimART Action    |    eTwinning Project
ClimART Action | eTwinning Projectjordimapav
 

Kürzlich hochgeladen (20)

4.9.24 Social Capital and Social Exclusion.pptx
4.9.24 Social Capital and Social Exclusion.pptx4.9.24 Social Capital and Social Exclusion.pptx
4.9.24 Social Capital and Social Exclusion.pptx
 
BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (GLOB...
BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (GLOB...BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (GLOB...
BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (GLOB...
 
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptxINCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
 
Paradigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTAParadigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTA
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdf
 
Satirical Depths - A Study of Gabriel Okara's Poem - 'You Laughed and Laughed...
Satirical Depths - A Study of Gabriel Okara's Poem - 'You Laughed and Laughed...Satirical Depths - A Study of Gabriel Okara's Poem - 'You Laughed and Laughed...
Satirical Depths - A Study of Gabriel Okara's Poem - 'You Laughed and Laughed...
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17
 
Indexing Structures in Database Management system.pdf
Indexing Structures in Database Management system.pdfIndexing Structures in Database Management system.pdf
Indexing Structures in Database Management system.pdf
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
 
MS4 level being good citizen -imperative- (1) (1).pdf
MS4 level   being good citizen -imperative- (1) (1).pdfMS4 level   being good citizen -imperative- (1) (1).pdf
MS4 level being good citizen -imperative- (1) (1).pdf
 
Mattingly "AI & Prompt Design: Large Language Models"
Mattingly "AI & Prompt Design: Large Language Models"Mattingly "AI & Prompt Design: Large Language Models"
Mattingly "AI & Prompt Design: Large Language Models"
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 Database
 
prashanth updated resume 2024 for Teaching Profession
prashanth updated resume 2024 for Teaching Professionprashanth updated resume 2024 for Teaching Profession
prashanth updated resume 2024 for Teaching Profession
 
Scientific Writing :Research Discourse
Scientific  Writing :Research  DiscourseScientific  Writing :Research  Discourse
Scientific Writing :Research Discourse
 
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQ-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
 
Employablity presentation and Future Career Plan.pptx
Employablity presentation and Future Career Plan.pptxEmployablity presentation and Future Career Plan.pptx
Employablity presentation and Future Career Plan.pptx
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentation
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management System
 
ClimART Action | eTwinning Project
ClimART Action    |    eTwinning ProjectClimART Action    |    eTwinning Project
ClimART Action | eTwinning Project
 
Mattingly "AI & Prompt Design" - Introduction to Machine Learning"
Mattingly "AI & Prompt Design" - Introduction to Machine Learning"Mattingly "AI & Prompt Design" - Introduction to Machine Learning"
Mattingly "AI & Prompt Design" - Introduction to Machine Learning"
 

Plastics

  • 1. EVICEL Fibrin Sealant (Human) Product Information EVICEL TM Fibrin Sealant (Human) PSR Sales Training Module
  • 2.
  • 3. Biosurgicals Products EVICEL* FIBRIN SEALANT (HUMAN) ORC (Oxidized Regenerated Cellulose) GELATIN FLOWABLE GELATIN COLLAGEN FIBRIN SEALANT SURGICEL* Hemostats SURGICEL FIBRILLAR* Hemostats SURGICEL NU-KNIT* Hemostats SURGIFOAM* GELATIN SPONGE & POWDER Hemostats INSTAT* MICROFIBRILLARCOLLAGEN Hemostats SURGIFOAM* POWDER Kit SURGIFLO* Hemostatic Matrix THROMBIN EVITHROM* Thrombin, Topical (Human)
  • 5. U.S. Fibrin Market *IMS Data, 2007 Vitagel EVICEL Tisseel 2006 Fibrin Market ($92 MM) 2007 Fibrin Market ($103 MM est.) Total fibrin market grew by 12% in 2007 Source: IMS 2007
  • 6. EVICEL Performance 2005 $183,364 $847,628 $1.2MM $1.9MM $2.2MM $2.2MM $3.1MM $3.6MM $4.2MM $5.3MM Launched EVICEL Launched CROSSEAL Launched EVICEL Vascular 2006 2007 $6.1MM $8.4 MM $7.1 MM Launched EVICEL General Hemostasis $8.8MM 2008 $10.4MM YTD in 2007 vs $17.7MM YTD in 2008 70% growth over 2007!!!
  • 7. 122% -15% 37% The Fibrin Sealants segment increased 18% over previous quarter and 14% over 4Q ’06 to $27.3M this quarter. Evicel leads the growth, with almost $5M growth in the past year and $0.7M in the past quarter. Although Tisseel is down over the past year, it rebounded in 4Q ’07 after its drop in 3Q ’07. Tisseel is cannibalizing its VH (nonfrozen) business with the newer frozen formulations which now account for 22% of its total dollar volume US Biosurgicals Market: Fibrin Sealants Detailed Segment, Short-term Dollar Performance 3 Month Quarters, $ Volume, in Millions Growth over Pr. Yr. Segment Volume (MM) $3.9 $5.8 $8.2 $8.3 $8.8 $17.0 $17.5 $14.3 $11.4 $12.0 $3.5 $3.4 $2.9 $3.5 $4.0 $- $5 $10 $15 $20 $25 $30 4Q '06 1Q '07 2Q '07 3Q '07 4Q '07 $, Millions Evicel Tisseel Vitagel Source: IMS HIS Data Compiled by: Pinky Shaw, BIWW
  • 8. Plastic/Burn Surgery Market Overview **NOTE: As always, promotion only for on-label surgeries for hemostasis $764MM 1,038,000 TOTAL $338MM 735,000 Breast (Reconstruction, Lift, Reduction and augmentation) (5 mL) $100MM 100,000 Burn Surgery (10 mL) $240MM 160,000 Abdominoplasty (15 mL) $86MM 43,000 Massive Weight Loss Body Contouring (20 mL) Potential Market (100% Penetration) Volume Procedure
  • 9.
  • 10. Background & New Indication
  • 11.
  • 12.
  • 13.
  • 14.
  • 15. New Indication for EVICEL TM EVICEL TM Fibrin Sealant (Human) is indicated as an adjunct to hemostasis for patients undergoing surgery when control of bleeding by standard surgical techniques is ineffective or impractical * Pending final labeling from FDA
  • 16. EVICEL ™ Fibrin Sealant (Human) Original Promotional Road Map Does the surgeon operate on the liver? Sales rep can also respond to a training request Sales rep or Medical Affairs * can respond to request for clinical info. Yes Yes You and the customer can initiate questions on EVICEL Fibrin Sealant (Human) for the approved indication Can you (sales rep) initiate conversation on EVICEL Fibrin Sealant (Human) for the approved indication? Can you (sales rep) respond to clinical questions on EVICEL Fibrin Sealant (Human) for the approved indication? Yes Only customers can initiate questions on EVICEL Fibrin Sealant (Human) No Only Medical Affairs * can respond to request for off-label clinical information on fibrin glue Sales rep could provide proper usage instructions upon request (including indications & safety information) to customers who decide to use the product Can you (sales rep) respond to off-label clinical questions on EVICEL Fibrin Sealant (Human)? Can you (Sales rep) initiate conversation on EVICEL Fibrin Sealant (Human)? No Training should include Indications, Contraindications, Precautions, Warnings, and the technical aspects of the product. * Pending final labeling from FDA No
  • 17. EVICEL ™ Fibrin Sealant (Human) Vascular Promotional Road Map Does the surgeon operate on the liver or perform vascular surgery? Sales rep can also respond to a training request Sales rep or Medical Affairs * can respond to request for clinical info. Yes Yes You and the customer can initiate questions on EVICEL Fibrin Sealant (Human) for the approved indication Can you (sales rep) initiate conversation on EVICEL Fibrin Sealant (Human) for the approved indication? Can you (sales rep) respond to clinical questions on EVICEL Fibrin Sealant (Human) for the approved indication? Yes Only customers can initiate questions on EVICEL Fibrin Sealant (Human) No Only Medical Affairs * can respond to request for off-label clinical information on fibrin glue Sales rep could provide proper usage instructions upon request (including indications & safety information) to customers who decide to use the product Can you (sales rep) respond to off-label clinical questions on EVICEL Fibrin Sealant (Human)? Can you (Sales rep) initiate conversation on EVICEL Fibrin Sealant (Human)? No Training should include Indications, Contraindications, Precautions, Warnings, and the technical aspects of the product. * Pending final labeling from FDA No
  • 18. EVICEL ™ Fibrin Sealant (Human) General Hemostasis Promotional Road Map Sales rep or Medical Affairs can respond to request for clinical info. Yes Yes You and the customer can initiate questions on EVICEL for the approved indication Can you (sales rep) initiate conversation on EVICEL for the approved indication? Can you (sales rep) respond to clinical questions on EVICEL for the approved indication? Only customers can initiate questions on EVICEL for off-label uses No, cannot promote for off-label uses, such as sealing and fixation Only Medical Affairs can respond to request for off-label clinical information on fibrin glues Can you (sales rep) respond to off-label clinical questions on EVICEL Fibrin Sealant (Human)? Can you (Sales rep) initiate conversation on off-label uses? No Training should include Indications, Contraindications, Precautions, Warnings, and the technical aspects of the product. Promote On-label for Hemostasis? Does the surgeon perform surgery? Yes * Pending final labeling from FDA No
  • 19.
  • 20. Leverage our Broad GH Indication Retroperitoneal Bleeding/Soft Tissue (3) Peripheral Vascular Surgery (2) Liver Resection Surgery (1) General Hemostasis Indication Studied in 3 different tissue types
  • 21.
  • 23.
  • 24.
  • 25.
  • 26. Clot Longevity Comparison* Longevity of the EVICEL TM Fibrin Sealant (Human) clot in vivo is comparable to that of CROSSEAL* Fibrin Sealant, and other marketed fibrin sealants such as Tisseel *Johnson & Johnson Wound Management Data on File, Data from in vitro animal model
  • 27. EVICEL TM Product Training
  • 28. Think EVICEL TM for your Plastic Surgery Procedures EVICEL TM is the first and only fibrin sealant approved for general hemostasis in surgery 1 TRAM Flap Abdominoplasty Think 1. Full Prescribing Information.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34. Device Overview 2 luer locks for easy removal and attachment of accessory tips Triple lumen 7cm clog resistant applicator tip Optional 35cm Rigid Tip Can be sprayed or dripped from the same device
  • 35. 35 cm Rigid Tip Overview EVICEL 35 cm Rigid Tip Packaging (3 per box) Ready to spray or drip One-Handed delivery Atraumatic & clog-resistant tip (triple lumen runs throughout tip) Attaches easily to the device
  • 36. Pressure Regulator EVICEL TM Fibrin Sealant (Human) should be sprayed using an air pressure of 20–25 psi measured by air flow* * EVICEL TM Fibrin Sealant (Human) Pressure Regulator Instructions for Use
  • 38.
  • 40. Updated Main Sales Aid NOW the only fibrin sealant approved for general hemostasis in surgery New Effective Bullet: Proven Rapid Hemostasis in vascular, urologic, gynecologic and general surgery New Soft Tissue Study data in general, gynecologic and urologic surgery * Pending final labeling from FDA; Draft Piece-Subject to change
  • 41. New Plastics Slim Jim Plastics Images (Breast Reconstruction) Hemostatic Efficacy (New Soft Tissue Study Data) in general, gynecologic and urologic surgery Experience the clear choice for your plastic surgery procedures Spray or drip EVICEL™ to achieve hemostasis during reconstructive procedures, including: breast reconstruction, abdominoplasty, facial reconstruction and vascular anastomoses * Subject to FDA Review * Pending final labeling from FDA; Draft Piece-Subject to change
  • 42.
  • 43. Product Preparation Poster New Cling-zee OR Wall Poster Easy preparation: No mixing required New easy-to-see images Preparation instructions for the 35 cm Rigid Tip
  • 45. New Customer In-service Deck (Updated with new indication & modular device) New Updated Website (New specialty tabs in Ortho, Burns & Plastics) New Blackberry Videos (3 new videos in Ortho, Burns & Plastics)
  • 46. EVICEL in Plastic Surgery Overview
  • 47. Plastic & Burn Specialty Overview
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.
  • 60. Q&A
  • 61.
  • 62.
  • 63.
  • 64.

Hinweis der Redaktion

  1. Looks okay as is.